Advagene Biopharma Co (ROCO:6709) ROE % Adjusted to Book Value : -4.71% (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Advagene Biopharma Co ROE % Adjusted to Book Value?

Advagene Biopharma Co's ROE % for the quarter that ended in Jun. 2023 was -85.99%. Advagene Biopharma Co's PB Ratio for the quarter that ended in Jun. 2023 was 18.26. Advagene Biopharma Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was -4.71%.

Advagene Biopharma Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Advagene Biopharma Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advagene Biopharma Co ROE % Adjusted to Book Value Chart

Advagene Biopharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-9.06

-5.00

-3.56

-5.52

-6.79

Advagene Biopharma Co Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial										-4.04	-5.54	-6.81	-4.71	-8.09

Competitive Comparison of Advagene Biopharma Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Advagene Biopharma Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advagene Biopharma Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advagene Biopharma Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Advagene Biopharma Co's ROE % Adjusted to Book Value falls into.

Advagene Biopharma Co ROE % Adjusted to Book Value Calculation

Advagene Biopharma Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-67.80%	/	9.99
	=	-6.79%

Advagene Biopharma Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-85.99%	/	18.26
	=	-4.71%

Advagene Biopharma Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Advagene Biopharma Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Advagene Biopharma Co (ROCO:6709) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advagene Biopharma Co Ltd (ROCO:6709) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114

Website

http://www.advagene.com.tw

Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.

Advagene Biopharma Co (ROCO:6709) Headlines

No Headlines